Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets
- PMID: 32493628
- DOI: 10.1016/j.molmed.2020.05.001
Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets
Abstract
Antibiotic resistance remains a significant threat to modern medicine. Modification of the antibiotic target is a resistance strategy that is increasingly prevalent among pathogens. Examples include resistance to glycopeptide and polymyxin antibiotics that occurs via chemical modification of their molecular targets in the cell envelope. Similarly, many ribosome-targeting antibiotics are impaired by methylation of the rRNA. In these cases, the antibiotic target is subjected to enzymatic modification rather than genetic mutation, and in many instances the resistance enzymes are readily mobilized among pathogens. Understanding the enzymes responsible for these modifications is crucial to combat resistance. Here, we review our current understanding of enzymatic modification of antibiotic targets as well as discuss efforts to combat these resistance mechanisms.
Keywords: adjuvant; antibiotic; glycopeptide; methyltransferase; polymyxin; resistance.
Copyright © 2020. Published by Elsevier Ltd.
Similar articles
-
Macrolide antibiotic interaction and resistance on the bacterial ribosome.Curr Opin Investig Drugs. 2003 Feb;4(2):140-8. Curr Opin Investig Drugs. 2003. PMID: 12669373 Review.
-
Mechanisms of bacterial biocide and antibiotic resistance.J Appl Microbiol. 2002;92 Suppl:55S-64S. J Appl Microbiol. 2002. PMID: 12000613 Review.
-
Translational control of antibiotic resistance.Open Biol. 2019 Jul 26;9(7):190051. doi: 10.1098/rsob.190051. Epub 2019 Jul 10. Open Biol. 2019. PMID: 31288624 Free PMC article. Review.
-
Mechanisms of bacterial biocide and antibiotic resistance.Symp Ser Soc Appl Microbiol. 2002;(31):55S-64S. Symp Ser Soc Appl Microbiol. 2002. PMID: 12481829 Review.
-
Bacterial resistance to antibiotics: enzymatic degradation and modification.Adv Drug Deliv Rev. 2005 Jul 29;57(10):1451-70. doi: 10.1016/j.addr.2005.04.002. Adv Drug Deliv Rev. 2005. PMID: 15950313 Review.
Cited by
-
Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria.Front Immunol. 2024 Feb 13;15:1352483. doi: 10.3389/fimmu.2024.1352483. eCollection 2024. Front Immunol. 2024. PMID: 38415251 Free PMC article.
-
16S rDNA-Based Amplicon Analysis Unveiled a Correlation Between the Bacterial Diversity and Antibiotic Resistance Genes of Bacteriome of Commercial Smokeless Tobacco Products.Appl Biochem Biotechnol. 2024 Feb 26. doi: 10.1007/s12010-024-04857-y. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 38407781
-
A Study of Resistome in Mexican Chili Powder as a Public Health Risk Factor.Antibiotics (Basel). 2024 Feb 13;13(2):182. doi: 10.3390/antibiotics13020182. Antibiotics (Basel). 2024. PMID: 38391568 Free PMC article.
-
Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens.Front Cell Infect Microbiol. 2023 Dec 20;13:1293633. doi: 10.3389/fcimb.2023.1293633. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38179424 Free PMC article. Review.
-
The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria.Int J Mol Sci. 2023 Oct 23;24(20):15493. doi: 10.3390/ijms242015493. Int J Mol Sci. 2023. PMID: 37895172 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
